Martin
Oncology
apitope
Belgium
Biography
Keith Martin is chief executive officer of Apitope. Dr Martin has enjoyed a career of more than 30 years in both large pharmaceutical companies and early stage biopharmaceutical companies. Dr Martin has held senior positions in research and development and corporate and business development as well as both executive and non-executive board positions with management and leadership roles in the UK, Belgium, the US and Spain. In addition, Dr Martin has developed products from bench to market and realised value through significant licensing deals as well being experienced in grants and venture investment. Dr Martin has been CEO of Apitope since April 2006.
Research Interest
Oncology
